Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses | Zendy

Masatsugu Hamaji | Zendy; Yukinori Matsuo | Zendy; Toyofumi F. ChenYoshikawa | Zendy; Takashi Mizowaki | Zendy; Hiroshi Date | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses

Author(s) -

Masatsugu Hamaji,

Yukinori Matsuo,

Toyofumi F. ChenYoshikawa,

Takashi Mizowaki,

Hiroshi Date

Publication year - 2019

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.10.35

Subject(s) - medicine , meta analysis , observational study , hazard ratio , lung cancer , stage (stratigraphy) , randomized controlled trial , odds ratio , oncology , radiation therapy , radiosurgery , surgery , confidence interval , paleontology , biology

Observational or randomized studies on survival outcome following surgery versus stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) demonstrated various results, and several meta-analyses on this topic have been published. The PubMed database was queried for meta-analyses comparing surgery and SBRT for early stage NSCLC. Six meta-analyses on this comparison were identified and 4 (66.7%) suggested that surgery be associated with significantly more favorable overall survival than SBRT, using odds ratio or hazard ratio (HR) as measures of effect. Most of the included studies in the meta-analyses were observational studies and those meta-analyses should be interpreted with caution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research